Parque Tecnológico de Galicia,
32911, San Cibrao Das Viñas (Ourense)


Origo Biopharma:

Origo Biopharma is a Spanish pharmaceutical company focused on research and development of novel immunotherapeutic pharmaceuticals with the purpose of introducing new compounds that addresses health disorders linked to dysfunction of TGF-beta signaling. We investigate on new compounds that show promising approaches for treatment of severe diseases such as cancer and fibrosis. OUR MISSION is the discovery and development of next generation therapeutic products for treatment of severe diseases linked to TGF-beta and OUR VISION is to improve life quality and ultimately cure people suffering from devastating conditions such as cancer.